Imprecise vowels represent a common deficit associated with hypokinetic dysarthria resulting from a reduced articulatory range of motion in Parkinson's disease (PD). It is not yet unknown whether the vowel articulation impairment is already evident in the prodromal stages of synucleinopathy. We aimed to assess whether vowel articulation abnormalities are present in isolated rapid eye movement sleep behaviour disorder (iRBD) and early-stage PD. A total of 180 male participants, including 60 iRBD, 60 de-novo PD and 60 age-matched healthy controls performed reading of a standardized passage. The first and second formant frequencies of the corner vowels /a/, /i/, and /u/ extracted from predefined words, were utilized to construct articulatory-acoustic measures of Vowel Space Area (VSA) and Vowel Articulation Index (VAI). Compared to controls, VSA was smaller in both iRBD (p = 0.01) and PD (p = 0.001) while VAI was lower only in PD (p = 0.002). iRBD subgroup with abnormal olfactory function had smaller VSA compared to iRBD subgroup with preserved olfactory function (p = 0.02). In PD patients, the extent of bradykinesia and rigidity correlated with VSA (r = -0.33, p = 0.01), while no correlation between axial gait symptoms or tremor and vowel articulation was detected. Vowel articulation impairment represents an early prodromal symptom in the disease process of synucleinopathy. Acoustic assessment of vowel articulation may provide a surrogate marker of synucleinopathy in scenarios where a single robust feature to monitor the dysarthria progression is needed.

Department of Circuit Theory Faculty of Electrical Engineering Czech Technical University Prague Prague Czech Republic

Department of Neurology and ARTORG Center Inselspital Bern University Hospital University of Bern Bern Switzerland

Department of Neurology and Centre of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Zobrazit více v PubMed

Boeve BF, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep. Med. 2013;14:754–762. doi: 10.1016/j.sleep.2012.10.015. PubMed DOI PMC

Miglis MG, et al. Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. Lancet Neurol. 2021;20:671–684. doi: 10.1016/S1474-4422(21)00176-9. PubMed DOI PMC

Dawson VL, Dawson TM. Promising disease-modifying therapies for Parkinson’s disease. Sci. Transl. Med. 2019;11:eaba1659. doi: 10.1126/scitranslmed.aba1659. PubMed DOI

Postuma RB, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142:744–759. doi: 10.1093/brain/awz030. PubMed DOI PMC

Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain. 2012;135:1860–1870. doi: 10.1093/brain/aws093. PubMed DOI

Duffy, J. R. Motor Speech Disorders - E-Book: Substrates, Differential Diagnosis, and Management. (Elsevier Health Sciences, 2013).

Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of patients with Parkinson’s disease. Behavioural Neurol. 1999;11:131–137. doi: 10.1155/1999/327643. PubMed DOI

Rusz J, et al. Defining speech subtypes in De Novo Parkinson Disease: response to long-term levodopa therapy. Neurology. 2021;97:e2124–e2135. doi: 10.1212/WNL.0000000000012878. PubMed DOI

Rusz J, et al. Automated speech analysis in early untreated Parkinson’s disease: relation to gender and dopaminergic transporter imaging. Eur. J. Neurol. 2022;29:81–90. doi: 10.1111/ene.15099. PubMed DOI

Darley FL, Aronson AE, Brown JR. Differential diagnostic patterns of dysarthria. J. Speech Hearing Res. 1969;12:246–269. doi: 10.1044/jshr.1202.246. PubMed DOI

Rusz J, et al. Speech biomarkers in rapid eye movement sleep behavior disorder and Parkinson disease. Ann. Neurol. 2021;90:62–75. doi: 10.1002/ana.26085. PubMed DOI PMC

Rusz J, et al. Dysprosody in isolated REM sleep behavior disorder with impaired olfaction but intact nigrostriatal pathway. Mov. Disord. 2022;37:619–623. doi: 10.1002/mds.28873. PubMed DOI

Braak H, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging. 2003;24:197–211. doi: 10.1016/S0197-4580(02)00065-9. PubMed DOI

Weismer G, Jeng J-Y, Laures JS, Kent RD, Kent JF. Acoustic and Intelligibility Characteristics of Sentence Production in Neurogenic Speech Disorders. Folia Phoniatr. Logop. 2001;53:1–18. doi: 10.1159/000052649. PubMed DOI

Lee J, Hustad KC. A preliminary investigation of longitudinal changes in speech production over 18 months in young children with cerebral palsy. Folia Phoniatr. Logop. 2013;65:32–39. doi: 10.1159/000334531. PubMed DOI PMC

Carl M, Icht M. Acoustic vowel analysis and speech intelligibility in young adult Hebrew speakers: Developmental dysarthria versus typical development. Int. J. Lang. Commun. Disord. 2021;56:283–298. doi: 10.1111/1460-6984.12598. PubMed DOI

Rusz J, et al. Imprecise vowel articulation as a potential early marker of Parkinson’s disease: Effect of speaking task. J. Acoustical Soc. Am. 2013;134:2171–2181. doi: 10.1121/1.4816541. PubMed DOI

Rusz J, et al. Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy. J. Neural Transm. 2013;120:319–329. doi: 10.1007/s00702-012-0853-4. PubMed DOI

Zhang SP, Bandler R, Davis PJ. Brain stem integration of vocalization: role of the nucleus retroambigualis. J. Neurophysiol. 1995;74:2500–2512. doi: 10.1152/jn.1995.74.6.2500. PubMed DOI

Skodda S, Grönheit W, Schlegel U. Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS ONE. 2012;7:e32132. doi: 10.1371/journal.pone.0032132. PubMed DOI PMC

Bonnet A-M, Loria Y, Saint-Hilaire M-H, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson’s disease result from nondopaminergic lesions? Neurology. 1987;37:1539–1539. doi: 10.1212/WNL.37.9.1539. PubMed DOI

Tripoliti E, et al. Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson’s disease. Mov. Disord. 2014;29:532–538. doi: 10.1002/mds.25816. PubMed DOI PMC

Cavallieri F, et al. Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson’s Disease. Front. Neurol. 2021;11:616062. doi: 10.3389/fneur.2020.616062. PubMed DOI PMC

Caverlé MWJ, Vogel AP. Stability, reliability, and sensitivity of acoustic measures of vowel space: A comparison of vowel space area, formant centralization ratio, and vowel articulation index. J. Acoustical Soc. Am. 2020;148:1436–1444. doi: 10.1121/10.0001931. PubMed DOI

Thies T, Mücke D, Dano R, Barbe MT. Levodopa-based changes on vocalic speech movements during prosodic prominence marking. Brain Sci. 2021;11:594. doi: 10.3390/brainsci11050594. PubMed DOI PMC

Thies T, et al. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities. Neuropsychologia. 2020;137:107306. doi: 10.1016/j.neuropsychologia.2019.107306. PubMed DOI

Mefferd AS, Dietrich MS. Tongue- and jaw-specific articulatory underpinnings of reduced and enhanced acoustic vowel contrast in talkers with Parkinson’s disease. J. Speech Lang. Hearing Res. 2019;62:2118–2132. doi: 10.1044/2019_JSLHR-S-MSC18-18-0192. PubMed DOI PMC

Hasegawa-Johnson M, Pizza S, Alwan A, Alwan JS, Haker K. Vowel category dependence of the relationship between palate height, tongue height, and oral area. J. J. Speech Lang. Hearing Res. 2003;46:738–753. doi: 10.1044/1092-4388(2003/059). PubMed DOI

Tjaden K, Rivera D, Wilding G, Turner GS. Characteristics of the lax vowel space in dysarthria. J. Speech, Lang., Hearing Res. 2005;48:554–566. doi: 10.1044/1092-4388(2005/038). PubMed DOI

Skodda S, Schlegel U. Speech rate and rhythm in Parkinson’s disease: Speech Rate and Rhythm in Parkinson’s Disease. Mov. Disord. 2008;23:985–992. doi: 10.1002/mds.21996. PubMed DOI

Delval A, et al. Freezing/festination during motor tasks in early-stage Parkinson’s disease: a prospective study. Mov. Disord. 2016;31:1837–1845. doi: 10.1002/mds.26762. PubMed DOI

Konstantopoulos, K., Vogazianos, P., Christou, Y. & Pisinou, M. Sequential motion rate and oral reading rate: normative data for Greek and clinical implications. Logopedics Phoniatrics Vocology 1–6 (2021). PubMed

Illner V, et al. Towards automated articulation rate analysis via connected speech in dysarthrias. J. Speech Lang. Hearing Res. 2022;65:1386–1401. doi: 10.1044/2021_JSLHR-21-00549. PubMed DOI

Hu MT. REM sleep behavior disorder (RBD) Neurobiol. Dis. 2020;143:104996. doi: 10.1016/j.nbd.2020.104996. PubMed DOI

Vorperian HK, et al. Developmental sexual dimorphism of the oral and pharyngeal portions of the vocal tract: an imaging study. J. Speech Lang. Hearing Res. 2011;54:995–1010. doi: 10.1044/1092-4388(2010/10-0097). PubMed DOI PMC

Hamdan A-L, Khalifee E, Ziade G, Semaan S. Sexual dimorphism in laryngeal volumetric measurements using magnetic resonance imaging. Ear, Nose Throat J. 2020;99:132–136. doi: 10.1177/0145561319840568. PubMed DOI

Mansukhani MP, Kolla BP, Ramar K. International classification of sleep disorders 2 and American Academy of Sleep Medicine Practice Parameters for Central Sleep Apnea. Sleep. Med. Clin. 2014;9:1–11. doi: 10.1016/j.jsmc.2013.10.006. DOI

Postuma RB, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov. Disord. 2015;30:1591–1601. doi: 10.1002/mds.26424. PubMed DOI

Martinez-Martin P, et al. Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) J. Neurol. 2013;260:228–236. doi: 10.1007/s00415-012-6624-1. PubMed DOI

Doty RL, Shaman P, Kimmelman CP, Dann MS. University of pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94:176–178. doi: 10.1288/00005537-198402000-00004. PubMed DOI

Kopecek M, et al. Montreal cognitive assessment (MoCA): normative data for old and very old Czech adults. Appl. Neuropsychology: Adult. 2017;24:23–29. doi: 10.1080/23279095.2015.1065261. PubMed DOI

Rusz J, Tykalova T, Ramig LO, Tripoliti E. Guidelines for speech recording and acoustic analyses in dysarthrias of movement disorders. Mov. Disord. 2021;36:803–814. doi: 10.1002/mds.28465. PubMed DOI

Sapir S, Spielman JL, Ramig LO, Story BH, Fox C. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. J. Speech Lang. Hearing Res. 2007;50:899–912. doi: 10.1044/1092-4388(2007/064). PubMed DOI

Sapir S, Ramig LO, Spielman JL, Fox C. Formant Centralization Ratio: A Proposal for a New Acoustic Measure of Dysarthric Speech. J. Speech Lang. Hearing Res. 2010;53:114–125. doi: 10.1044/1092-4388(2009/08-0184). PubMed DOI PMC

Skodda S, Visser W, Schlegel U. Vowel Articulation in Parkinson’s Disease. J. Voice. 2011;25:467–472. doi: 10.1016/j.jvoice.2010.01.009. PubMed DOI

Kent RD, Vorperian HK. Static measurements of vowel formant frequencies and bandwidths: A review. J. Commun. Disord. 2018;74:74–97. doi: 10.1016/j.jcomdis.2018.05.004. PubMed DOI PMC

Fant, G. Speech Sounds and Features (MIT Press, Cambridge, MA,1973).

Liu H-M, Tsao F-M, Kuhl P. The effect of reduced vowel working space on speech intelligibility in Mandarin-speaking young adults with cerebral palsy. J. Acoustical Soc. Am. 2005;117:3879–3889. doi: 10.1121/1.1898623. PubMed DOI

Roy N, Nissen SL, Dromey C, Sapir S. Articulatory changes in muscle tension dysphonia: Evidence of vowel space expansion following manual circumlaryngeal therapy. J. Commun. Disord. 2009;42:124–135. doi: 10.1016/j.jcomdis.2008.10.001. PubMed DOI

Tykalova T, et al. Effect of ageing on acoustic characteristics of voice pitch and formants in Czech vowels. J. Voice. 2020;35:931.e21–931.e33. doi: 10.1016/j.jvoice.2020.02.022. PubMed DOI

Darcourt J, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur. J. Nucl. Med. Mol. Imaging. 2010;37:443–450. doi: 10.1007/s00259-009-1267-x. PubMed DOI

Dusek P, et al. Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder. Sci. Rep. 2019;9:15463. doi: 10.1038/s41598-019-51710-y. PubMed DOI PMC

Calvini P, et al. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur. J. Nucl. Med Mol. Imaging. 2007;34:1240–1253. doi: 10.1007/s00259-006-0357-2. PubMed DOI